RPRX
Royalty Pharma plc · Healthcare
EVP and CFO Terrance P. Coyne sold $3.5M of Royalty Pharma plc
Sold$3,476,116
$53.98Price
64,399Shares
−100%Stake
What RPRX did after the filing
- The stock from Fri, May 29 open, $54.48
- +2.2%
- S&P 500, same days
- −0.5%
Measured over 30 trading days, to the Jul 14 close.
Traded Tue, May 26. Filed Thu, May 28, 4:48 PM ET, after the close. Returns use the May 29 open and the Jul 14 close. Not investment advice.